Panel Discussion | Challenges and Opportunities for Innovation in 2026

Sunday, March 8, 2026

3:12 PM - 3:32 PM EST

Location: International Ballroom West

Moderator(s)

Steven R. Bailey, MD, MSCAI

Professor of Medicine
LSU Health Shreveport
San Antonio, Texas, United States

Disclosure information not submitted.
James B. Hermiller, MD, FACC, MSCAI

Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States

Disclosure(s): Edwards, Abbott: Consulting Fees (e.g., advisory boards) (Ongoing)
Stanton J. Rowe, PhD

CEO
Nidus Biomedical
Irvine, California, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Gary M. Ansel, MD, FACC

Founder
Healthcare Inroads
Columbus , Ohio, United States

Disclosure information not submitted.
Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure(s): ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)
Nabil Dib, MD, MSc, FACC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

Disclosure(s): No financial relationships to disclose
Nicolas Foin, MSc, PhD

Founder/ Adj Associate Professor
Dhenin/ Duke-NUS Medical School
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Disclosure information not submitted.
Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

Interventional Cardiologist
John Muir Health Cardiovascular Institute
San Francisco, California, United States

Disclosure(s): AtaCor: Stock Options [in privately held companies] (Ongoing)
Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

Professor of Medicine
Dartmouth Health Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States

Disclosure information not submitted.
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Israel Barbash, MD: No financial relationships to disclose

Stanton J. Rowe, PhD: No financial relationships to disclose

Rafael Beyar, MD, DSc, MPH: ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Nabil Dib, MD, MSc, FACC: No financial relationships to disclose

Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC: AtaCor: Stock Options [in privately held companies] (Ongoing)

Chaim Shaul Lotan, MD: No financial relationships to disclose